| AASLD

Aryl hydrocarbon receptor–fibroblast growth factor 21 dissociation of fatty liver from insulin resistance: A timely matter?

Read more about Aryl hydrocarbon receptor–fibroblast growth factor 21 dissociation of fatty liver from insulin resistance: A timely matter?

Manlio Vinciguerra, Gianluigi Mazzoccoli – 25 June 2015

Liver transplantation in patients with end‐stage liver disease requiring intensive care unit admission and intubation

Read more about Liver transplantation in patients with end‐stage liver disease requiring intensive care unit admission and intubation

Eric Levesque, Moez Khemiss, Zaid Noorah, Cyrille Feray, Daniel Azoulay, Gilles Dhonneur – 25 June 2015

Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

Read more about Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

AASLD/IDSA HCV Guidance Panel – 25 June 2015

Na+/H+ exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury

Read more about Na+/H+ exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury

Man Li, Albert Mennone, Carol J. Soroka, Lee R. Hagey, Xinshou Ouyang, Edward J. Weinman, James L. Boyer – 25 June 2015 – The intercellular adhesion molecule 1 (ICAM‐1) is induced in mouse liver after bile duct ligation (BDL) and plays a key role in neutrophil‐mediated liver injury in BDL mice. ICAM‐1 has been shown to interact with cytoskeletal ezrin‐radixin‐moesin (ERM) proteins that also interact with the PDZ protein, Na+/H+ exchanger regulatory factor 1 (NHERF‐1/EBP50). In NHERF‐1−/− mice, ERM proteins are significantly reduced in brush‐border membranes from kidney and small intestine.

Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

Read more about Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

AASLD/IDSA HCV Guidance Panel – 25 June 2015

Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin‐1

Read more about Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin‐1

Lucía Barbier‐Torres, Naiara Beraza, Pablo Fernández‐Tussy, Fernando Lopitz‐Otsoa, David Fernández‐Ramos, Imanol Zubiete‐Franco, Marta Varela‐Rey, Teresa C. Delgado, Virginia Gutiérrez, Juan Anguita, Albert Pares, Jesús M. Banales, Erica Villa, Juan Caballería, Luis Alvarez, Shelly C. Lu, Jose M. Mato, María Luz Martínez‐Chantar – 25 June 2015 – Prohibitin‐1 (PHB1) is an evolutionarily conserved pleiotropic protein that participates in diverse processes depending on its subcellular localization and interactome.